BRUZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 11.494
EU - Europa 8.660
AS - Asia 6.005
SA - Sud America 709
AF - Africa 172
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 10
Totale 27.137
Nazione #
US - Stati Uniti d'America 11.251
IT - Italia 3.081
GB - Regno Unito 2.178
SG - Singapore 2.055
CN - Cina 1.771
HK - Hong Kong 842
SE - Svezia 766
DE - Germania 764
BR - Brasile 555
VN - Vietnam 330
RU - Federazione Russa 320
UA - Ucraina 290
FR - Francia 276
FI - Finlandia 263
TR - Turchia 232
IN - India 148
CA - Canada 137
ID - Indonesia 132
BG - Bulgaria 118
NL - Olanda 118
KR - Corea 111
JP - Giappone 87
AU - Australia 67
PL - Polonia 64
IE - Irlanda 62
LT - Lituania 62
MX - Messico 62
ZA - Sudafrica 62
ES - Italia 61
AR - Argentina 54
IR - Iran 47
EG - Egitto 45
BD - Bangladesh 41
DK - Danimarca 38
IQ - Iraq 36
CZ - Repubblica Ceca 32
AT - Austria 31
BE - Belgio 31
BZ - Belize 31
CH - Svizzera 30
PK - Pakistan 29
MY - Malesia 25
CO - Colombia 24
VE - Venezuela 22
NZ - Nuova Zelanda 20
IL - Israele 17
RO - Romania 17
EC - Ecuador 16
TW - Taiwan 16
SA - Arabia Saudita 15
MA - Marocco 11
PT - Portogallo 11
PY - Paraguay 11
KE - Kenya 10
EU - Europa 9
GR - Grecia 9
PE - Perù 9
RS - Serbia 9
TH - Thailandia 9
UG - Uganda 9
AE - Emirati Arabi Uniti 8
KW - Kuwait 8
CL - Cile 6
ET - Etiopia 6
PH - Filippine 6
TN - Tunisia 6
UZ - Uzbekistan 6
BO - Bolivia 5
DZ - Algeria 5
HU - Ungheria 5
JO - Giordania 5
LB - Libano 5
UY - Uruguay 5
KZ - Kazakistan 4
AM - Armenia 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GH - Ghana 3
LK - Sri Lanka 3
ME - Montenegro 3
PA - Panama 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
GY - Guiana 2
HN - Honduras 2
MT - Malta 2
NA - Namibia 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SM - San Marino 2
SN - Senegal 2
AO - Angola 1
BT - Bhutan 1
Totale 27.119
Città #
Santa Clara 1.515
Southend 1.483
Singapore 1.414
Ashburn 1.046
Hong Kong 819
Chandler 800
Fairfield 777
Woodbridge 571
Houston 507
Hefei 471
Jacksonville 464
Dearborn 448
Nyköping 418
London 336
Beijing 330
Seattle 290
Ann Arbor 285
Wilmington 278
Cambridge 237
Rome 229
Milan 223
Munich 200
Los Angeles 191
New York 179
Helsinki 148
Bologna 140
Princeton 127
Ho Chi Minh City 110
Sofia 108
Chicago 101
Izmir 98
Seoul 98
Jakarta 97
Eugene 96
Modena 96
San Diego 96
Moscow 94
The Dalles 93
Bremen 92
Naples 92
Shanghai 91
Frankfurt am Main 84
Redwood City 79
Buffalo 73
San Jose 68
Council Bluffs 66
São Paulo 62
Dallas 56
Columbus 53
Hanoi 53
Turin 51
Florence 50
Fremont 48
Tokyo 48
Boardman 45
Verona 45
Johannesburg 43
Montreal 40
Warsaw 40
Dublin 39
Phoenix 39
Las Vegas 35
Poplar 35
Turku 34
Dong Ket 33
Cairo 32
Toronto 32
Belize City 31
Denver 31
Des Moines 31
Falls Church 31
Palermo 31
Bari 30
Redondo Beach 30
Albuquerque 28
Salt Lake City 28
Brooklyn 27
Nuremberg 27
Padova 26
Parma 26
Brno 25
Guangzhou 25
Orem 25
Portsmouth 25
Atlanta 24
Chennai 24
Norwalk 24
Reggio Emilia 24
Boston 23
Brussels 23
Brescia 22
Kent 22
Stockholm 22
Catania 21
Mexico City 21
Nanjing 21
Ottawa 21
Düsseldorf 19
Kunming 19
Lauterbourg 19
Totale 17.397
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.067
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 616
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 435
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 406
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 339
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 335
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 335
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 326
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 321
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 320
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 320
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 317
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 303
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 303
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 303
L’ipercolesterolemia familiare: terapia farmacologica 300
Approaches to dyslipidemia treatment in children and adolescents 287
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 266
COVID-19 and Type 1 Diabetes: Concerns and Challenges 262
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 257
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 257
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 257
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 256
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 255
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 254
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 251
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 246
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 246
Hypercholesterolemia in Childhood 238
Un dolore che sveglia di notte [Pain that wakes you up at night...] 237
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 233
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 231
Endocrine Disrupting Chemicals and Type 1 Diabetes 231
Novel insights on the treatment of hypercholesterolemia 230
Occhio alla macrorchidia! 228
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 227
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 226
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 224
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 223
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 222
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 222
Iper CPKemia, non solo miopatie 219
Can inflammatory marker levels help in detecting early complications of childhood obesity? 216
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 216
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 213
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 213
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 212
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 211
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 207
Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism 207
Obesity and craniopharyngioma. 206
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency 206
Study of inflammations' markers and insulin resistance in obese children and adolescents with and without non-alcoholic fatty liver disease. 204
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 204
Quality of life in children and adolescents with type 1 diabetes and coeliac disease. 203
High levels of serum perfluorinated compounds in children and adolescents with endocrine autoimmune disease 203
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 202
EFFETTI DI UN ANNO DI PANDEMIA COVID-19 SU PARAMETRI AUXOLOGICI E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1. 202
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes 201
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 201
Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence? 201
A Novel Mutation in the TITF1 Gene in a Child with Benign Hereditary Chorea 198
Storia naturale dell’ipotiroidismo congenito: cosa è cambiato negli ultimi vent’anni? 198
Ten-Year Longitudinal Study of Thyroid Function in Children with Down's Syndrome 196
Uso delle gonadotropine urinarie per la valutazione del profilo minipuberale in neonati e lattanti di sesso maschile 196
Mi presento, senza tosse– amyco plasma 193
Le merendine sono tutte uguali? Quale colazione per i bambini?. 193
A comparative study on the incidence of type 1 diabetes mellitus between children of North African migrants and Italian children in Emilia-Romagna region, Italy 192
Malattia celiaca e patologie endocrine autoimmuni 191
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 189
Arresto di crescita nei primi mesi di vita: quando l’ipolipidemia e la steatorrea fanno diagnosi. 187
Nutrizione e diabete: punti fermi e spunti di riflessione 186
Central Precocious Puberty in Cerebral Palsy 184
Evaluation of the quality of life in children and adolescents with type 1 diabetes, coeliac disease and healthy controls. 183
Torcicollo A Tuttalè! (Note) Coccolini, E.a, Bruzzi, P.b, Bergonzini, P.b, Iughetti, L.ab 183
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition 182
Crescita e malattia celiaca 181
The Role of 24-h Ambulatory Blood Pressure Monitoring in Children and Adolescents with Type 1 Diabetes: Early Experience of a Single Centre 179
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 178
Obesity in patients with acute lymphoblastic leukemia in childhood. 175
Metabolic Assessment in Children with GH Deficiency Before, During, and After Human GH Replacement Therapy 172
Diagnosi genetica e valutazione della funzione endoteliale in adolescenti affetti da ipercolesterolemia familiare. 170
Circulating miR146a and 486-5p are Altered in Obese Children with and Without Non-Alcoholic Fatty LiverDisease (NAFLD) and Correlate with Abdominal Fat and BMI 169
Longitudinal study of endothelial function in children with familial hypercholesterolemia. 167
Usefulness of CGM with iPro2 in children with T1DM and correlations between Glucose Variability and metabolic control 165
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 165
Efficacy, safety and tolerability of statin therapy in adolescents with familial hypercholesterolaemia 163
Malattia celiaca, una rivisitazione patogenetica e clinica. 162
Human Placenta-Derived Mesenchymal Stem Cells: A Novel Protocol for Pancreatic Differentiation 162
Obesity in adolescence: Its prevention and psycho-social aspects [Prevenzione e aspetti psico-sociali dell'obesità in età evolutiva] 158
The Metabolic Negative Effect of Gonadotropin-Releasing Hormone Agonist Therapy in Childhood: Is it Short-Term and Reversible? 158
The Risk of Metabolic Syndrome among Dyslipidemic Children and Adolescents 158
The impact of diabetes and celiac disease in the quality of life in children and adolescents. 157
Disordini del comportamento alimentare e diabete mellito tipo 1 in età evolutiva: un'associazione più frequente di quanto ci si potrebbe attendere 152
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 151
Longitudinal study of endothelial function in children with type 1 diabetes mellitus 149
Early-life exposure to phthalates in a population of infants from the north of Italy: characterization and time trends 147
Unforgettable cases in pediatric general practice: HyperCPKemia (high creatine phosphokinase blood levels), not just myopathy [IperCPKemia, non solo miopatie] 146
The Efficacy of Insulin Degludec in Children and Adolescents with Type 1 Diabetes 146
Copy Number Variation Analysis Increases the Number of Candidate Loci Associated with Pediatric Obesity 141
Totale 23.281
Categoria #
all - tutte 97.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.441 0 0 0 0 0 227 316 242 115 224 175 142
2021/20222.269 74 211 143 199 171 139 105 127 213 189 437 261
2022/20232.998 314 281 212 256 373 376 104 278 324 106 194 180
2023/20242.454 136 133 162 246 383 272 168 282 96 100 193 283
2024/20256.443 199 133 167 426 1.090 1.010 569 376 898 323 513 739
2025/20265.213 734 347 757 1.248 1.822 305 0 0 0 0 0 0
Totale 27.494